Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Simon Lichtiger"'
Publikováno v:
Inflammatory Bowel Diseases. 28:1938-1938
Autor:
Andrew, Leber, Raquel, Hontecillas, Nuria, Tubau-Juni, Simon, Lichtiger, Josep, Bassaganya-Riera
Publikováno v:
Gastroenterology. 162:S112
BACKGROUND Omilancor is an oral, once-daily, gut-restricted, small molecule, first-in-class therapeutic for Crohn’s disease (CD) and ulcerative colitis (UC) that targets the novel LANCL2 pathway. Through LANCL2 activation, omilancor increases the s
Autor:
Jordan E. Axelrad, Yael R. Nobel, Suzanne K. Lewis, Simon Lichtiger, Susan Whittier, Garrett Lawlor, Benjamin Lebwohl, Peter H.R. Green
Publikováno v:
Digestive Diseases and Sciences. 63:996-1002
Patients with celiac disease and inflammatory bowel disease, two immune-mediated luminal conditions, have higher rates of certain infections than healthy counterparts. The prevalence of many gastrointestinal infections in these patients, however, is
Autor:
Simon Lichtiger, Peter H.R. Green, Benjamin Lebwohl, Garrett Lawlor, Jordan E. Axelrad, Andrew M. Joelson
Publikováno v:
Gastroenterology. 154:S98-S100
Autor:
Lindsay D. Kumble, Garrett Lawlor, Aaron Oh, Simon Lichtiger, Timothy Wen, Maria T. Abreu, Adam S. Faye, Ravi P. Kiran, Chin Hur
Publikováno v:
Inflamm Bowel Dis
BackgroundIleal pouch–anal anastomosis (IPAA) is the mainstay of surgical treatment for patients with ulcerative colitis (UC) but is associated with an increased risk of infertility. We developed a simulation model examining the impact of initial s
Autor:
Frank J. Attenello, William J. Mack, Benjamin Lebwohl, Adam S. Faye, Gilaad G. Kaplan, Simon Lichtiger, Garrett Lawlor, Alexander M. Friedman, Timothy Wen, Ashwin N. Ananthakrishnan, Jason D. Wright
Publikováno v:
Clin Gastroenterol Hepatol
Background & Aims Patients with inflammatory bowel diseases (IBDs) have a high risk of venous thromboembolism (VTE). We assessed the timing and risk factors associated with readmission to the hospital for VTE among patients with IBD. Methods We colle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fc86c229d4b027204e74533b6df46f8
https://europepmc.org/articles/PMC6980437/
https://europepmc.org/articles/PMC6980437/
Autor:
Simon Lichtiger
Publikováno v:
Gastrointestinal endoscopy clinics of North America. 29(3)
Autor:
Abhik Roy, Simon Lichtiger
Publikováno v:
Inflammatory Bowel Diseases. 22:648-653
Dysbiosis refers to an alteration in the bacterial composition of the bowel. Dysbiosis is considered to play a significant role in the pathogenesis of numerous conditions affecting human health, including Crohn’s disease (CD). A rapidly increasing
Autor:
Jordan E. Axelrad, Garrett Lawlor, Ken Cadwell, Peter H.R. Green, Andrew M. Joelson, Benjamin Lebwohl, Simon Lichtiger
Publikováno v:
Am J Gastroenterol
OBJECTIVES: Few studies have examined the role of non-Clostridium difficile enteric infections in flares of inflammatory bowel disease (IBD). Our objective was to investigate enteric infection detected by multiplex PCR stool testing in patients with
Autor:
Adam S. Faye, Kenneth Hung, Jon W. Blackett, Adam R. Pont, Garrett Lawlor, Simon Lichtiger, Benjamin Lebwohl, Daniel E. Freedberg
Publikováno v:
Gastroenterology. 157:e24-e25